2m 2m 2m 2m 2m 2m 2m
Exicure (XCUR)
NASDAQ
$3.09-$0.02 (-0.80%)
Price as of Jun 03, 2026 4:04 PM EDT- $20.3MMarket Cap
- -70.01%1-Year Change
- BiotechnologyIndustry
Exicure (XCUR)
$3.09-$0.02 (-0.80%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 -100.00% | 500,000 N/A | 0 -100.00% | 28.8M +6,068.12% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 -100.00% | 500,000 N/A | 0 -100.00% | 28.8M +6,068.12% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -3.3M N/A | 0 +100.00% | -1.4M -92.80% | -19.8M -59.64% | |
Depreciation and Amortization Expense | 242,000 +764.29% | 28,000 -95.58% | 634,000 -45.49% | 1.2M +3.56% | |
Total Operating Expenses | 4.2M -66.75% | 12.7M -15.10% | 15.0M -51.08% | 30.7M -50.61% | |
Operating Profit | -4.2M -65.39% | -12.2M -18.43% | -15.0M +719.01% | -1.8M -97.07% | |
Interest Income | 29,000 +262.50% | 8,000 -75.00% | 32,000 +113.33% | 15,000 -89.36% | |
Interest Expense | N/A N/A | N/A N/A | 0 +100.00% | -595,000 -64.81% | |
Interest Income and Expense and Net | 29,000 +262.50% | 8,000 -75.00% | 32,000 +105.52% | -580,000 -62.58% | |
Total Nonoperating Income and Expense | -1.3M -153.05% | 2.5M +232.38% | -1.9M +253.87% | -542,000 -65.10% | |
Income before Taxes | -5.6M -42.43% | -9.7M -42.69% | -16.9M +612.77% | -2.4M -96.30% | |
Income Taxes | -634,000 -8,025.00% | 8,000 N/A | 0 -100.00% | 209,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -4.9M -49.02% | -9.7M -42.65% | -16.9M +555.07% | -2.6M -95.97% | |
Net Income from Continuing Operations Applicable to Common | -5.6M -42.43% | -9.7M -42.69% | -16.9M +612.77% | -2.4M -96.30% | |
Basic EPS and Net Income | -0.79 -83.37% | -4.75 +125.12% | -2.11 +276.79% | -0.56 -22.22% | |
Diluted EPS and Net Income | -0.79 -83.37% | -4.75 +125.12% | -2.11 +276.79% | -0.56 -22.22% | |
Basic Weighted Average Shares | 6.3M +208.19% | 2.0M -74.50% | 8.0M +73.48% | 4.6M -94.79% | |
Diluted Weighted Average Shares | 6.3M +208.19% | 2.0M -74.50% | 8.0M +73.48% | 4.6M -94.79% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.7M -70.05% | 12.5M +1,432.84% | 816,000 -90.49% | 8.6M -75.24% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Cash and Cash Equivalents and Short-Term Investments | 3.7M -70.05% | 12.5M +1,432.84% | 816,000 -90.49% | 8.6M -78.09% | |
Total Current Assets | 4.6M -66.18% | 13.7M +575.54% | 2.0M -79.86% | 10.1M -76.98% | |
Accumulated Depreciation | 195,000 -22.92% | 253,000 +12.44% | 225,000 -93.84% | 3.6M +36.86% | |
Property and Plant and Equipment and Net | 306,000 +1,076.92% | 26,000 -51.85% | 54,000 -97.87% | 2.5M -35.57% | |
Total Long-Term Assets | 928,000 -31.61% | 1.4M -54.54% | 3.0M -14.47% | 3.5M -62.57% | |
Total Assets | 14.0M -6.74% | 15.1M +30.02% | 11.6M -50.36% | 23.3M -64.04% | |
Income Taxes Payable | 423,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Total Current Liabilities | 3.9M +26.60% | 3.1M +22.35% | 2.5M +53.14% | 1.6M -95.19% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 846,000 -83.77% | 5.2M -13.68% | 6.0M N/A | 0 -100.00% | |
Total Liabilities | 10.1M +22.10% | 8.3M -3.10% | 8.5M +1.70% | 8.4M -84.33% | |
Retained Earnings | -204.2M +2.48% | -199.3M +5.12% | -189.6M +9.80% | -172.6M +1.52% | |
Total Stockholders Equity | 3.9M -42.03% | 6.8M +123.42% | 3.0M -79.69% | 14.9M +32.85% | |
Total Shares Outstanding | 6.4M +5.76% | 6.0M -30.33% | 8.7M +74.20% | 5.0M -95.44% | |
Cash Flow | |||||
Cash from Operating Activities | -8.6M +193.99% | -2.9M -71.90% | -10.4M -70.95% | -35.7M +2.41% | |
Capital Expenditures | 1,000 N/A | N/A N/A | 0 -100.00% | 10,000 -98.97% | |
Cash from Investing Activities | -1.8M N/A | 0 +100.00% | -1.1M -122.96% | 4.7M -89.10% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.6M -88.06% | 13.4M +264.78% | 3.7M +218.33% | -3.1M -378.23% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | -2,446.40% N/A | N/A N/A | -6.35% -100.05% | |
Return on Assets | -34.00% -53.33% | -72.84% -24.83% | -96.91% +1,555.07% | -5.86% -92.45% | |
Return on Equity | -92.47% -53.28% | -197.92% +5.04% | -188.43% +854.31% | -19.74% -88.80% | |
Revenue Growth | -100.00% N/A | N/A N/A | -100.00% -101.65% | 6,068.12% +5,996.68% | |
Current Ratio | 1.19 -73.29% | 4.45 +452.12% | 0.81 -86.85% | 6.13 +378.42% | |
Cash Ratio | 0.96 -76.34% | 4.07 +1,152.81% | 0.33 -93.79% | 5.23 +414.61% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow